ARCHIVES

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

This article is from The Cancer Letter archive.

Vol. 07 No. 03 | January 16, 1981

Download PDF Visit The Full Archive

Related Articles

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005